Generics 4

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Lafutidine manufacturers

4 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

4 products found

lafutidine

Tablets 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, TGA
Manufacturer #18120
This globally competitive organization specializes in formulating a wide range of medications and exports to over 40 countries. Their state-of-the-art manufacturing facilities are strategically located across three cities, adhering to stringent regulatory standards like those set by the EU, UK, and UNICEF. They produce diverse dosage forms including tablets, capsules, creams, ointments, gels, and sterile formulations such as lyophilized products and prefilled syringes. Key therapy areas include complex generics, orphan drugs, and treatments for neglected tropical diseases. The company holds GMP certifications and possesses product patents, emphasizing their commitment to quality and innovation. They actively participate in global initiatives, providing emergency stockpiles for coronavirus treatments and partnering with organizations to address the healthcare needs of Palestinian refugees.

Manufacturer usually replies in 7 days

lafutidine

Tablets 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20511

This CTD dossier owner and manufacturer has a strong commitment to improving health and well-being at every stage of life. Founded in 2002, it has grown from 400 employees to over 3,000, operating from its headquarters in Mumbai and across 329 locations nationwide. With state-of-the-art manufacturing facilities in Asia, the company produces over 170 products across acute and semi-chronic therapies. A dedicated R&D center in Pune, approved by DSIR, drives innovation in healthcare solutions. Ranked 7th in its directly covered market and 23rd overall in India, the company focuses on quality, social responsibility, employee welfare, and environmental sustainability, aiming to make a lasting impact on society and promote a healthier future.

Manufacturer usually replies in 21 days

lafutidine + domperidone

Tablets 10 mg + 30 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20511

This CTD dossier owner and manufacturer has a strong commitment to improving health and well-being at every stage of life. Founded in 2002, it has grown from 400 employees to over 3,000, operating from its headquarters in Mumbai and across 329 locations nationwide. With state-of-the-art manufacturing facilities in Asia, the company produces over 170 products across acute and semi-chronic therapies. A dedicated R&D center in Pune, approved by DSIR, drives innovation in healthcare solutions. Ranked 7th in its directly covered market and 23rd overall in India, the company focuses on quality, social responsibility, employee welfare, and environmental sustainability, aiming to make a lasting impact on society and promote a healthier future.

Manufacturer usually replies in 21 days

Want to see all 4 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible